Please login to the form below

Not currently logged in
Email:
Password:

drug discovery

This page shows the latest drug discovery news and features for those working in and with pharma, biotech and healthcare.

AbbVie to acquire Allergan for $63bn

AbbVie to acquire Allergan for $63bn

Allergan also lacks a pedigree in drug discovery and development, but has tried to make up for this only in recent years, setting up an R&D presence in Cambridge, Mass

Latest news

More from news
Approximately 10 fully matching, plus 376 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    genetic research through to drug development in pharma, and into leadership of several successful UK biotech firms. ... 6. PROF. JOANNA HOLBROOK. Professor Joanna Holbrook is director, translational biology at BenevolentAI, pioneers of AI-based drug

  • The first, my last, my everything The first, my last, my everything

    The rationale is clear: “If you want to demonstrate the value of your medicine, it’s critically important that you’ve engaged patients throughout the journey from drug discovery to treatment

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    Its high prices are controversial, but Vertex also embodies the best of biopharma drug development. ... Ex-Merck &Co. scientist Joshua Boger did want the company to pioneer rationale drug discovery and development, however, and after.

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    This evidence has spurred research and led. organisations including the Alzheimer’s Drug Discovery Foundation and AC Immune to conclude that combination therapies may be needed to tackle such a complex ... Read more: Brain power: fresh approaches to

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    The EPAD and its novel trial concept will hopefully help speed-up the drug discovery progress and bring us closer to this ambitious aim.”. ... We are delighted to collaborate as part of the Dementia Consortium, and we believe this is an exciting

More from intelligence
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 73 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics